Treatment of hypertension based on measurement of blood pressure variability: Lessons from animal studies

Current Opinion in Cardiology

Volumn 21, Issue 5, 2006, Pages 486-491

  Su, Ding Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Arterial baroreflex; Blood pressure; Blood pressure variability; End organ damage; Hypertension; Sinoaortic denervation

Indexed keywords

ALPHA TOCOPHEROL; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CANDESARTAN; CHLORISONDAMINE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; INDOMETACIN; KETANSERIN; NITRENDIPINE; RESERPINE;

AORTA HYPERTROPHY; APOPTOSIS; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; COMPARATIVE STUDY; ENDOTHELIUM LESION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HYPERTENSION; INFLAMMATION; KIDNEY INJURY; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASCULAR FIBROSIS; VASODILATATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; APOPTOSIS; BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; HEART DISEASES; HYPERTENSION; INFLAMMATION; KIDNEY DISEASES; RATS; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS;

EID: 33747053911     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hco.0000240587.14463.58     Document Type: Review

References (35)

1. Parati G, Pomidossi G, Albini F, et al. Relationship of 24-hour blood pressure mean and variability to severity of target organ damage in hypertension. J Hypertens 1987; 5:93-98.
2. Frattola A, Parati G, Cuspidi C, et al. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993; 11:1133-1137.
3. Su DF, Miao CY. Reduction of blood pressure variability: a new strategy for the treatment of hypertension. Trends Pharmacol Sci 2005; 26:388-390.
4. Bunag RD. Measurement of blood pressure in rats. In: de Jong W, editor. Handbook of hypertension. Experimental and genetic models of hypertension. Amsterdam: Elsevier Science BV; 1984. pp. 1-12.
5. Su DF, Xu LP, Miao CY, et al. Two useful methods for evaluating antihypertensive drugs in conscious freely moving rats. Acta Pharmacol Sin 2004; 25:148-151.
6. Julien C. Pharmacological attenuation of blood pressure variability. Acta Pharmacol Sin 2005; 26:1288-1289.
7. Chapuis B, Vidal-Petiot E, Orea V, et al. Linear modeling analysis of baroreflex control of arterial pressure variability in rats. J Physiol 2004; 559:639-649.
8. Parati G. Blood pressure variability, target organ damage and antihypertensive treatment. J Hypertens 2003; 21:1827-1830.
9. Su DF, Miao CY. Blood pressure variability and organ damage. Clin Exp Pharmacol Physiol 2001; 28:709-715.
10. Miao CY, Xie HH, Zhan LS, Su DF. Blood pressure variability is more important than blood pressure level in determination of end-organ damage in rats. J Hypertens 2006; 24 (6):1137-1146.
11. Xie HH, Shen FM, Miao CY, Su DF. Blood pressure, baroreflex sensitivity and end organ damage in hybrid offspring of SHR and SD rats. Acta Pharmacol Sin 2005; 26:1049-1056.
12. Miao CY, Su DF. The importance of blood pressure variability in rat aortic and left ventricular hypertrophy produced by sinoaortic denervation. J Hypertens 2002; 20:1865-1872.
13. Miao CY, Yuan WJ, Su DF. Comparative study of sinoaortic denervated rats and spontaneously hypertensive rats. Am J Hypertens 2003; 16:585-591.
14. Shen FM, Zhang SH, Xie HH, Su DF. Early structural changes of aortic wall in sinoaortic denervated rats. Clin Exp Pharmacol Physiol 2006; 33:358-363.
15. 1 receptor in hypertrophied ventricles and aortas of sinoaortic-denervated rats. Acta Pharmacol Sin 2003; 24:812-818.
16. Martinka P, Fielitz J, Patzak A, et al. Mechanisms of blood pressure variability-induced cardiac hypertrophy and dysfunction in mice with impaired baroreflex. Am J Physiol Regul Intergr Comp Physiol 2004; 288:R767-R776.
17. Miao CY, Tao X, Gong K, et al. Arterial remodeling in chronic sinoaortic-denervated rats. J Cardiovasc Pharmacol 2001; 37:6-15.
18. Shan ZZ, Dai SM, Su DF. Arterial baroreflex deficit induced organ damage in sinoaortic denervated rats. J Cardiovasc Pharmacol 2001; 38:427-437.
19. Zhang C, Chen H, Xie HH, et al. Inflammation is involved in the organ damages induced by sinoaortic denervation in rats. J Hypertens 2003; 21:2141-2148.
20. Katori M. Do studies on a sinoaortic denervation model give a clue to the mechanisms of cardiovascular and renal damage in hypertension. J Hypertens 2003; 21:2019-2021.
21. Tao X, Zhang SH, Chu ZX, Su DF. Apoptosis is involved in the cardiac damage induced by sinoaortic denervation in rats. Clin Exp Pharmacol Physiol 2003; 30:362-368.
22. Tao X, Zhang SH, Shen FM, Su DF. High-level apoptosis is persistent in myocardiocytes of sinoaortic-denervated rats. J Hypertens 2004; 22:557-563.
23. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999; 79:215-262.
24. Du WM, Miao CY, Liu JG, et al. Effects of long-term treatment with ketanserin on blood pressure variability and end-organ damage in spontaneously hypertensive rats. J Cardiovasc Pharmacol 2003; 41:233-239.
25. Xu LP, Miao CY, Shen FM, et al. Synergism of atenolol and amlodipine on lowering and stabilizing blood pressure in spontaneously hypertensive rats. Fundam Clin Pharmacol 2004; 18:33-38.
26. Fu YJ, Shu H, Miao CY, et al. Restoration of baroreflex function by ketanserin is not blood pressure dependent in conscious freely moving rats. J Hypertens 2004; 22:1165-1172.
27. Liu JG, Xu LP, Chu ZX, et al. Contribution of blood pressure variability to the effect of nitrendipine on end-organ damage in spontaneously hypertensive rats. J Hypertens 2003; 21:1961-1967.
28. 1 receptors in the regulating of blood pressure variability in conscious rats. Acad J Sec Mil Med Univ 1997; 18:342-345.
29. Miao CY, Xie HH, Yu H, et al. Ketanserin stabilizes blood pressure in conscious spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2003; 30:189-193.
30. Fu YJ, Wang WZ, Cai GJ, et al. Action site of ketanserin enhancing baroreflex function is within the rostral ventrolateral medulla in anesthetized rats. Auton Neurosci 2006; 124:31-37.
31. Xie HH, Miao CY, Jiang YY, Su DF. Synergism of atenolol and nitrendipine on hemodynamic amelioration and organ protection in hypertensive rats. J Hypertens 2005; 23:193-201. Studies looking at the decrease in BPV and the restoration of baroreflex sensitivity, which may importantly contribute to organ protection in SHRs with chronic treatment.
32. Xie HH, Chen YY, Miao CY, et al. Blood pressure variability reduction and baroreflex sensitivity restoration contribute to organ protection in spontaneously hypertensive rats treated with candesartan. Cardiovasc Drug Ther 2005; 19 (6):391-397.
33. Xie HH, Shen FM, Cao YB, et al. Effects of low-dose ketanserin on blood pressure variability, baroreflex sensitivity and end-organ damage in spontaneously hypertensive rats. Clin Sci 2005; 108:547-552. Low-dose ketanserin produces organ protection independently of its blood pressure-lowering action in SHRs, and this organ protection was importantly attributable to the enhancement of baroreflex sensitivity and a decrease in BPV.
34. Lu ZA, Xie HH, Xu LP, et al. Restoration of arterial baroreflex function contributes to organ protection in spontaneously hypertensive rats treated with long-term hydrochlorothiazide mixture. Clin Exp Pharmacol Physiol 2003; 30:49-54.
35. Shen FM, Xie HH, Lin G, et al. Synergistic effects of atenolol and amlodipine for lowering and stabilizing blood pressure in 2K1C renovascular hypertensive rats. Acta Pharmacol Sin 2005; 26:1303-1308. A study showing significant synergism between atenolol and amlodipine in lowering and stabilizing blood pressure in two kidney one clip renovascular hypertensive rats.